Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

terbinafine

terbinafine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
LamISIL GRANULE, ORAL 125 mg, 187.5 mg    
LamISIL TABLET, ORAL 250 mg      
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

terbinafine (LamISIL)

  • 125 mg granule oral                                                            
  • 187.5 mg granule oral

terbinafine (LamISIL)

  • HALF 250 mg tablet (Total: 125 mg)
  • 250 mg tablet

LamISIL medication guide

Reviewed: May 27, 2008 (LamISIL granules)

Last updated: Aug. 18, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved